Partner Julie Tibbets shares why generic drug makers and marketers must carefully adhere to the U.S. Food and Drug Administration’s requirements for promoting drug products and why knowing common pitfalls is so important to avoiding regulatory scrutiny and ensuring compliant promotional conduct.
Read the full article.